Capacitive Diathermy in the Lumbopelvic Pain

NCT ID: NCT02736201

Last Updated: 2016-10-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-05-31

Study Completion Date

2017-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objective: To determine the effectiveness of the capacitive diathermy in the mechanosensitivity, morphological, functional and contractility changes in patients with lumbopelvic pain.

Design: A pilot study, single blind, randomized controlled clinical trial, approved previously by The Princess University Hospital Ethics Committee (Feb 11, 2016) and the European University clinical intervention review board (CIPI/054/15).

Setting: Faculty of Health Sciences, Exercise and Sport. European University of Madrid.

Patients and intervention: A sample of 20 patients with bilateral lumbopelvic pain, between 18 and 60 years old, will be recruited and randomized into 2 intervention groups. The instrumental manual therapy with the switched on capacitive diathermy electrode (IMT+ T-CaRe®on; n = 10) and the instrumental manual therapy with the switched off capacitive diathermy electrode (IMT+ T-CaRe®off; n = 10) will be bilaterally treated for 4 weeks (1 treatment per week during 10 minutes) in the lumbopelvic region.

Outcome measurements: Control variables such as the age, sex, height, weight, body mass index, Borg scale physical activity and distress respiratory test will be measured at the beginning of the treatment. Dependent variables such as the pain intensity, the pressure pain threshold, the contractility, the stiffness, the adverse effects, the Oswestry and Schöber test, as well as the ultrasound imaging cross sectional area and thickness of the skin, subcutaneous tissue, connective tissue, L4 multifidus and the abdominal Wall (rectus anterior, externus oblique, internal oblique and transversus abdominis) will be assessed before and after each intervention by a blinded examiner.

Analysis data: The statistical analysis will be performed with a 95% confidence interval and the Statistic Package Social Sciences (SPSS) 22.0.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Back Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IMT+ T-CaRe®on; n = 10

The instrumental manual therapy with the switched on capacitive diathermy electrode

Group Type EXPERIMENTAL

Capacitive diathermy (T-CaRe®)

Intervention Type DEVICE

The instrumental manual therapy with the switched on capacitive diathermy electrode (IMT+ T-CaRe® on; n = 10) and the instrumental manual therapy with the switched off capacitive diathermy electrode (IMT+ T-CaRe® off; n = 10) will be bilaterally treated for 4 weeks (1 treatment per week during 10 minutes) in the lumbopelvic region.

Instrumental manual therapy

Intervention Type OTHER

Bilateral longitudinal massage in the lumbar region (110 mm; 5 minutes in each side)

IMT+ T-CaRe® off; n = 10

The instrumental manual therapy with the switched off capacitive diathermy electrode

Group Type SHAM_COMPARATOR

Capacitive diathermy (T-CaRe®)

Intervention Type DEVICE

The instrumental manual therapy with the switched on capacitive diathermy electrode (IMT+ T-CaRe® on; n = 10) and the instrumental manual therapy with the switched off capacitive diathermy electrode (IMT+ T-CaRe® off; n = 10) will be bilaterally treated for 4 weeks (1 treatment per week during 10 minutes) in the lumbopelvic region.

Instrumental manual therapy

Intervention Type OTHER

Bilateral longitudinal massage in the lumbar region (110 mm; 5 minutes in each side)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Capacitive diathermy (T-CaRe®)

The instrumental manual therapy with the switched on capacitive diathermy electrode (IMT+ T-CaRe® on; n = 10) and the instrumental manual therapy with the switched off capacitive diathermy electrode (IMT+ T-CaRe® off; n = 10) will be bilaterally treated for 4 weeks (1 treatment per week during 10 minutes) in the lumbopelvic region.

Intervention Type DEVICE

Instrumental manual therapy

Bilateral longitudinal massage in the lumbar region (110 mm; 5 minutes in each side)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* bilateral lumbopelvic pain for 6 weeks

Exclusion Criteria

* neuromuscular conditions
* negative straight leg raise test
* respiratory or congenital conditions
* surgeries
* neurologic signs
* lower extremities conditions
* skin alterations
* cognitive disorders
* body mass index higher than 31 kg/cm2
* skin alterations
* pregnancy
* intensive physical activity
* Nijmegen test higher than 24
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

European University of Madrid

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

César Calvo Lobo, PhD, MSc, PT

Role: PRINCIPAL_INVESTIGATOR

European University of Madrid

David Rodríguez Sanz, PhD, MSc, PT

Role: PRINCIPAL_INVESTIGATOR

European University of Madrid

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

European University of Madrid

Villaviciosa de Odón, Madrid, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Cesar Calvo Lobo, PhD, MSc, PT

Role: CONTACT

0034-912-115-268 ext. 5268

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

César Calvo Lobo, PhD, MSc, PT

Role: primary

0034-912-115-268 ext. 5268

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CIPI/054/15

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.